🇰🇷 Fabrazyme in South Korea

Fabrazyme (AGALSIDASE BETA) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Fabrazyme in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in South Korea

Frequently asked questions

Is Fabrazyme approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Fabrazyme in South Korea?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.